Pharmaceutical firms’ finance costs jump 46.5% amid high interest rates

Nigerian pharmaceutical companies listed on the Nigerian Exchange recorded a 46.5 per cent increase in combined finance costs in the first quarter of 2026, as high interest rates and growing reliance on debt continued to squeeze profitability across the sector. For stock market-listed companies, finance costs (also called finance expenses or borrowing costs) are the […]